In Q3 2019, Bausch Health delivered another strong quarter with both reported and organic revenue growth.
Southern California-based Sienna Biopharmaceuticals filed for bankruptcy, which sent share prices tumbling more than 73 percent.
In Q3 2019, Bausch Health delivered another strong quarter with both reported and organic revenue growth.
Southern California-based Sienna Biopharmaceuticals filed for bankruptcy, which sent share prices tumbling more than 73 percent.